Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer types

Affiliations

• ¹ University of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK.
• ² Astra Zeneca, Cambridge, UK.
• ³ University of Cambridge, Department of Biochemistry, Tennis Court Road, Cambridge, CB2 1QW, UK.
• ⁴ MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
• ⁵ University of Cambridge, Yusuf Hamied Department of Chemistry, Lensfield Road, Cambridge, CB2 1EW, UK.
• ⁶ Bicycle Therapeutics, Cambridge, UK.
• ⁷ Charles River Laboratories, Saffron Walden, UK.
• ⁸ University of Cambridge, Department of Pathology, Tennis Court Road, Cambridge, CB2 1QP, UK.
• ⁹ Institute of Pathology, University of Bern, Murtenstrasse 31, CH-3008, Bern, Switzerland.
• ¹⁰ University of Cambridge, MRC Toxicology Unit, Tennis Court Road, Cambridge, CB2 1QR, UK.
• ¹¹ Department of Histopathology, Cambridge University Hospitals, NHS Foundation Trust, Main Drive, Cambridge, CB2 0QQ, UK.
• ¹² University of Cambridge, Department of Haematology, Puddicombe Way, Cambridge, CB2 0AW, UK.
• ¹³ Rigshospitalet-University Hospital Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark.
• ¹⁴ Institute of Immunology and Microbiology, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
• ¹⁵ Novo Nordisk, Måløv, Denmark.
• ¹⁶ University of Southern Denmark Campusvej 55, Odense M, DK-5230, Denmark.
• ¹⁷ University of Cambridge, Department of Biochemistry, Tennis Court Road, Cambridge, CB2 1QW, UK. [email protected].
• ¹⁸ University of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK. [email protected].